Comparison ofHER2 status in breast cancer using fluorescent in situ hybridisation and immunohistochemistry at National Hospital Abuja, Nigeria - a case for alternate testing in developing countries

Wanka A. N. Ado; Amin S.; Taniere P.; Jibrin P.; Shaaban A.

首页> 外文期刊>Virchows Archiv: an international journal of pathology >Comparison ofHER2 status in breast cancer using fluorescent in situ hybridisation and immunohistochemistry at National Hospital Abuja, Nigeria - a case for alternate testing in developing countries

【24h】

Comparison ofHER2 status in breast cancer using fluorescent in situ hybridisation and immunohistochemistry at National Hospital Abuja, Nigeria - a case for alternate testing in developing countries

机译：尼日利亚国家医院原位杂交和免疫组化的乳腺癌中的乳腺癌中的比较 - 以发展中国家的替代测试为例

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Virchows Archiv: an international journal of pathology》 |2019年第1期|共1页
作者
Wanka A. N. Ado; Amin S.; Taniere P.; Jibrin P.; Shaaban A.;
展开▼
作者单位

Natl Hosp Abuja Abuja Nigeria;

Natl Hosp Abuja Abuja Nigeria;

Queen Elizabeth Hosp Birmingham W Midlands England;

Natl Hosp Abuja Abuja Nigeria;

Queen Elizabeth Hosp Birmingham W Midlands England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学微生物学（病原细菌学、病原微生物学）;
关键词

相似文献

外文文献
中文文献
专利

1. Comparison ofHER2 status in breast cancer using fluorescent in situ hybridisation and immunohistochemistry at National Hospital Abuja, Nigeria - a case for alternate testing in developing countries [J] . Wanka A. N. Ado, Amin S., Taniere P., Virchows Archiv: an international journal of pathology . 2019,第Suppla1期

机译：尼日利亚国家医院原位杂交和免疫组化的乳腺癌中的乳腺癌中的比较 - 以发展中国家的替代测试为例
2. Comparison of Chromogenic In Situ Hybridisation with Fluorescence In Situ Hybridisation and Immunohistochemistry for the Assessment of Her-2eu Oncogene in Archival Material of Breast Carcinoma [J] . Alexios Pothos, Konstantina Plastira, Aris Plastiras, Acta histochemica et cytochemica . 2008,第1a6期

机译：彩色原位杂交与荧光原位杂交和免疫组织化学比较评估乳腺癌档案材料中的Her-2 / neu癌基因
3. Central retesting of breast cancer with HER2 immunohistochemistry score of 0 or 1+ using silver-enhanced in situ hybridisation: a multicentre, prospective study in Greece [J] . Savvas Papadopoulos, Petroula Arapantoni-Dadioti, Konstantinos Sfikas, Forum of Clinical Oncology . 2014,第1期

机译：使用银增强原位杂交技术对HER2免疫组化分数为0或1+的乳腺癌进行中央再检测：希腊的一项多中心，前瞻性研究
4. Laboratory assessment of the status of Her-2eu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assays [O] . S Wang, M Saboorian, E Frenkel, 2000

机译：乳腺癌标本中Her-2 / neu蛋白和癌基因状态的实验室评估：免疫组织化学法与荧光原位杂交法的比较
5. Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assays [O] . Wang, S, Saboorian, M, Frenkel, E, 2000

机译：乳腺癌标本中Her-2 / neu蛋白和癌基因状态的实验室评估：免疫组织化学法与荧光原位杂交法的比较

Comparison ofHER2 status in breast cancer using fluorescent in situ hybridisation and immunohistochemistry at National Hospital Abuja, Nigeria - a case for alternate testing in developing countries

著录项

相似文献

相关主题

期刊订阅